Observation of Therapy With Micardis® (Telmisartan) in Patients With Essential Hypertension in Hospitals

• Status: Completed
• Trial end date: 1969-12-31

Summary

The aim of the observational study was to supplement the data on efficacy, safety and tolerability of telmisartan under daily conditions in hospitals

Details

• Lead Sponsor: Boehringer Ingelheim
• Treatments: Telmisartan